` Comparison: SN vs SYK - Alpha Spread

SN
vs
SYK

Over the past 12 months, SN has outperformed SYK, delivering a return of +11% compared to the SYK's 4% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
SN
SYK
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

SN Intrinsic Value
HIDDEN
Show
SYK Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Smith & Nephew PLC
LSE:SN
1 284 GBX
Stryker Corp
NYSE:SYK
364.09 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
SN, SYK

Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Smith & Nephew PLC
Revenue
Stryker Corp
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
SN, SYK

Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Smith & Nephew PLC
LSE:SN
Stryker Corp
NYSE:SYK
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

SN
68%
SYK
64.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Smith & Nephew PLC
Stryker Corp

Operating Margin

SN
16.8%
SYK
22.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Smith & Nephew PLC
Stryker Corp

Net Margin

SN
10.1%
SYK
12.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Smith & Nephew PLC
Stryker Corp

FCF Margin

SN
13.8%
SYK
17.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Smith & Nephew PLC
Stryker Corp

ROE

SN
11.8%
SYK
15.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Smith & Nephew PLC
Stryker Corp

ROA

SN
6%
SYK
7.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Smith & Nephew PLC
Stryker Corp

ROIC

SN
9.6%
SYK
10.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Smith & Nephew PLC
Stryker Corp

ROCE

SN
11.7%
SYK
15.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Smith & Nephew PLC
Stryker Corp

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
SN, SYK

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
SN, SYK

Performance Gap Between SN and SYK
HIDDEN
Show

Performance By Year
SN, SYK

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare SN to other stocks
ABT
Abbott Laboratories
Cheaper
vs SN
ISRG
Intuitive Surgical Inc
More expensive
vs SN
MDT
Medtronic PLC
Cheaper
vs SN
BSX
Boston Scientific Corp
Cheaper
vs SN
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett